ArticleJournal of cellular and molecular medicine2019

PCSK9 inhibitor improves cardiac function and reduces infarct size in rats with ischaemia/reperfusion injury: Benefits beyond lipid-lowering effects.

Siripong Palee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.